• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time.

作者信息

Deymeer F, Serdaroğlu P, Poda M, Gülşen-Parman Y, Ozçelik T, Ozdemir C

机构信息

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Turkey.

出版信息

Neuromuscul Disord. 1997 Dec;7(8):521-8. doi: 10.1016/s0960-8966(97)00113-2.

DOI:10.1016/s0960-8966(97)00113-2
PMID:9447610
Abstract

We examined 26 spinal muscular atrophy type III (SMA III) patients with SMNt deletions, searching for possible segmental distribution of muscle weakness. In those with disease duration of < or = 11 years, the weakest muscles were upper lumbar innervated ones in the lower extremities. In the upper extremities, early involvement of triceps muscle suggested the possibility of lower cervical (C7) onset. Electrophysiologically, weaker muscles had a more severe reduction in the recruitment pattern, particularly in the lower extremities. However, severe reduction in recruitment was sometimes also observed in clinically strong muscles. In patients with disease duration of > or = 16 years and regardless of disease duration, in those with disease onset at < or = 3 years of age, weakness and severe electrophysiological changes were more widespread. These findings may suggest a progression in muscle weakness with time. When compared to 12 patients with Becker muscular dystrophy (BMD), early stage SMA III with weak iliopsoas-strong gluteus maximus stood in contrast to BMD with weak gluteus maximus-strong iliopsoas.

摘要

相似文献

1
Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time.
Neuromuscul Disord. 1997 Dec;7(8):521-8. doi: 10.1016/s0960-8966(97)00113-2.
2
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.180 例脊髓性肌萎缩症 1c-4 型患者的横断面队列研究中贯穿一生的肌肉力量和运动功能。
Eur J Neurol. 2018 Mar;25(3):512-518. doi: 10.1111/ene.13534. Epub 2018 Feb 2.
3
Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.SMA IIIb型的自然病史:肌肉力量按可预测的顺序和程度下降。
Neurology. 2008 Aug 26;71(9):644-9. doi: 10.1212/01.wnl.0000324623.89105.c4.
4
Becker muscular dystrophy or spinal muscular atrophy?--Dystrophin studies resolve conflicting results of electromyography and muscle biopsy.
Neuromuscul Disord. 1991;1(3):195-200. doi: 10.1016/0960-8966(91)90024-m.
5
Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.常染色体隐性遗传性脊髓性肌萎缩症5q13染色体上候选基因的分子分析:未患病个体中SMN基因纯合缺失的证据。
Hum Mol Genet. 1995 Oct;4(10):1927-33. doi: 10.1093/hmg/4.10.1927.
6
Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy.神经解剖学模型对肌肉力量的影响及其与脊髓性肌萎缩症患者步行功能的关系。
J Neuromuscul Dis. 2020;7(4):459-466. doi: 10.3233/JND-200550.
7
Cramps and minimal EMG abnormalities as preclinical manifestations of spinal muscular atrophy patients with homozygous deletions of the SMN gene.痉挛和轻微肌电图异常作为脊髓性肌萎缩症患者纯合缺失SMN基因的临床前表现。
Neurology. 1997 May;48(5):1443-5. doi: 10.1212/wnl.48.5.1443.
8
Cough, sniff and maximal static pressure patterns in spinal muscular atrophy.咳嗽、鼻塞和最大静态压力模式在脊髓性肌萎缩症中的表现。
Respir Physiol Neurobiol. 2020 Jan;271:103308. doi: 10.1016/j.resp.2019.103308. Epub 2019 Sep 24.
9
A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy.II型脊髓性肌萎缩症与杜氏肌营养不良症的步态比较。
Gait Posture. 2005 Jun;21(4):369-78. doi: 10.1016/j.gaitpost.2004.04.006.
10
Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy.脊髓性肌萎缩症无症状携带者中生存运动神经元(SMNT)基因缺失的特征分析。
Hum Mol Genet. 1996 Mar;5(3):359-65. doi: 10.1093/hmg/5.3.359.

引用本文的文献

1
Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.本体感觉突触功能障碍是脊髓性肌萎缩症小鼠和人类的一个关键特征。
Brain. 2025 Feb 21. doi: 10.1093/brain/awaf074.
2
Brain magnetic resonance imaging of patients with spinal muscular atrophy type 2 and 3.2 型和 3 型脊肌萎缩症患者的脑部磁共振成像。
Neuroimage Clin. 2024;44:103708. doi: 10.1016/j.nicl.2024.103708. Epub 2024 Nov 14.
3
Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy.
本体感觉感觉突触功能障碍是脊髓性肌萎缩症小鼠和人类的致病事件及治疗靶点。
medRxiv. 2024 Jun 4:2024.06.03.24308132. doi: 10.1101/2024.06.03.24308132.
4
Multi-parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophy.脊髓性肌萎缩症患者上臂肌肉的多参数定量磁共振成像。
NMR Biomed. 2022 Jul;35(7):e4696. doi: 10.1002/nbm.4696. Epub 2022 Feb 14.
5
Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy.神经解剖学模型对肌肉力量的影响及其与脊髓性肌萎缩症患者步行功能的关系。
J Neuromuscul Dis. 2020;7(4):459-466. doi: 10.3233/JND-200550.
6
MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.2 型和 3 型脊肌萎缩症患者的肌肉受累的 MRI 模式。
J Neurol. 2020 Apr;267(4):898-912. doi: 10.1007/s00415-019-09646-w. Epub 2019 Nov 27.
7
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).一项评估吡啶斯的明对2-4型脊髓性肌萎缩症患者疗效的II期、单中心、双盲、安慰剂对照、交叉试验方案(SPACE试验)。
BMJ Open. 2018 Jul 30;8(7):e019932. doi: 10.1136/bmjopen-2017-019932.
8
Segmental Spinal Muscular Atrophy Localised to the Lower Limbs: First case from Oman.局限于下肢的节段性脊髓性肌萎缩:阿曼首例病例。
Sultan Qaboos Univ Med J. 2017 Aug;17(3):e355-e357. doi: 10.18295/squmj.2017.17.03.018. Epub 2017 Oct 10.
9
Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative?门诊脊髓性肌萎缩症运动的单盲、随机、对照临床试验:为何结果为阴性?
J Neuromuscul Dis. 2015 Oct 7;2(4):463-470. doi: 10.3233/JND-150101.